IconOVir Bio Alternatives & Competitors
12 companies similar to IconOVir Bio — Pushing the envelope: Our mission is to cure cancer and restore life to every pa...
Companies similar to IconOVir Bio
Epitopea
Exploiting a new class of tumour specific antigens for cancer therapy
Montreal, Canada
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Rival Readout
Competing with IconOVir Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
Boston, United States
Treeline
Making medicines at the highest level
Watertown, United States
Modalis Therapeutics
Modalis is an emerging biotech company that develops therapeutics using CRISPR based techn...
Cambridge, United States
Seneca Therapeutics, Inc.
Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for...
Philadelphia, United Stat...
Avelos Therapeutics
Strive for a Better Tomorrow.
Seoul, Korea South
Amyl Therapeutics
Restoring clarity in amyloid diseases
Liege, Belgium
About IconOVir Bio
IconOVir Bio, founded in 2018, is a preclinical-stage biotechnology company headquartered in the United States. The company focuses on pioneering next-generation oncolytic virus therapies to enhance cancer treatment, addressing the limitations found in earlier generations of oncolytic viruses. This cutting-edge platfor...
cancer cure development, oncology treatments, biopharmaceutical innovation
cancer patients, healthcare providers, hospitals, clinical research organizations
Oncolytic Virus Therapy, Cancer Treatment, Preclinical-stage, Proprietary Platform, Scientific Founder, Oncolytic Viruses, Cancer Research, Technology Development, Innovation, Life Sciences, Salk Institute, Clinical Trials, Genetic Engineering, Precision Medicine
B2B, Platform
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around IconOVir Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at IconOVir Bio on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
